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Summary
This systematic review and meta-analysis of effectiveness trials comparing
multicomponent behavioural weight management programmes with controls in
overweight and obese adults set out to determine the effectiveness of these inter-
ventions implemented in routine practice. To be included, interventions must have
been multicomponent, delivered by the therapists who would deliver the inter-
vention in routine practice and in that same context, and must be widely available
or feasible to implement with little additional infrastructure or staffing. Searches
of electronic databases were conducted, and augmented by screening reference
lists and contacting experts (November 2012). Data were extracted by two
reviewers, with mean difference between intervention and control for 12-month
change in weight, blood pressure, lipids and glucose calculated using baseline
observation carried forward. Data were also extracted on adverse events, quality
of life and mood measures. Although there were many published efficacy trials,
only eight effectiveness trials met the inclusion criteria. Pooled results from five
study arms providing access to commercial weight management programmes
detected significant weight loss at 12 months (mean difference −2.22 kg, 95%
confidence interval [CI] −2.90 to −1.54). Results from two arms of a study testing
a commercial programme providing meal replacements also detected significant
weight loss (mean difference −6.83 kg, 95% CI −8.39 to −5.26). In contrast,
pooled results from five interventions delivered by primary care teams showed no
evidence of an effect on weight (mean difference −0.45 kg, 95% CI −1.34 to 0.43).
One study testing an interactive web-based intervention detected a significant
effect in favour of the intervention at 12 months, but the study was judged to be
at high risk of bias and the effect did not persist at 18 months. Few studies
reported other outcomes, limiting comparisons between interventions. Few trials
have examined the effectiveness of behavioural weight loss programmes delivered
in everyday contexts. These trials suggest that commercial interventions delivered
in the community are effective for achieving weight loss. There is no evidence that
interventions delivered within primary care settings by generalist primary care
teams trained in weight management achieve meaningful weight loss.
Keywords: Adult, behaviour therapy, obesity, weight loss.
Abbreviations: BMI, body mass index; kg, kilogramme.
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Introduction
The World Health Organization estimates that, every year,
overweight and obesity cause at least 2.8 million deaths
and the loss of 35.8 million disability-adjusted life years,
imposing a penalty on individuals and a large financial
burden on health care systems and the wider economy
(1,2). Multicomponent behavioural weight management
programmes, incorporating diet, exercise and behavioural
counselling, can lead to significant weight loss, but their
efficacy is highly variable (3,4).
Much of the evidence on these programmes comes from
efficacy trials of interventions designed and delivered by
specialist researchers and provides proof of principle that
this kind of programme can work, typically in ideal cir-
cumstances. Such data can establish the efficacy of these
programmes, but do not necessarily establish their effec-
tiveness in everyday practice. The Dietary Approaches to
Stop Hypertension (DASH) trials illustrate this distinction.
In a proof of principle trial, consumption of the DASH diet
reduced blood pressure by 6/3 mm of mercury compared
with control (5) and an intensive behavioural intervention
delivered by a dietician-produced similar reductions (6).
However, a pragmatic trial of a DASH intervention deliv-
ered by generalists (primary care nurses) had negligible
effects on blood pressure (7). These trials indicate the
context and person who delivers the intervention are criti-
cal to its success. Several systematic reviews have examined
the efficacy of behavioural weight loss interventions, but
without an explicit focus on whether the intervention was
delivered in the setting in which it would be delivered
outside of a trial and by personnel who would be involved
in programme delivery in routine practice (3,4,8–10). In
addition, studies of weight management programmes often
have high attrition levels, and researchers use different
approaches to participants lost to follow-up, with some
presenting complete case data, and others using a variety of
imputation methods for missing data. Previous reviews
have taken weight change outcomes as reported and syn-
thesized this. Such synthesis risks introducing spurious dif-
ferences between studies.
We aimed to determine the clinical effectiveness of
multicomponent behavioural weight management pro-
grammes for overweight and obese adults compared with
minimal intervention controls, as tested in randomized con-
trolled trials. To inform implementation in practice, we
included only those interventions that are already widely
available or may be readily implemented with current or
minimal additional infrastructure or staffing and tested in
the same context as would be used to implement these
programmes outside of a trial. In particular, to be included,
the people delivering the intervention had to be available
outside of a trial context and interventions had to be deliv-
ered in the same setting in the trial that would apply in a
wider roll-out (e.g. commercial programmes in their
standard settings, primary care-delivered interventions in
primary care). To ensure that spurious differences between
programmes were not introduced because of different
approaches to accounting for participants lost to follow-
up, we recalculated outcomes using a consistent approach
across all included studies.
Methods
A review protocol was agreed prior to commencing work
(see File S1). We searched BIOSIS, the Cochrane Database
of Systematic Reviews, CENTRAL, the Conference Pro-
ceedings Citation Index, the Database of Abstracts of
Reviews and Effects, EMBASE, the Health Technology
Assessment database, MEDLINE, PsycINFO, and the
Science Citation Index in November 2012 for randomized
and quasi-randomized controlled trials, using terms for
overweight and obesity, diet and exercise, and weight loss
interventions. We used the comprehensive search in a
review of behavioural weight management programmes to
identify studies published prior to May 2009 and updated
this (3). The electronic search strategy for MEDLINE is
listed in Table S1. We also screened references from system-
atic reviews and primary studies identified through our
search and sought further studies from experts in the field.
Searches were not restricted by country or language.
Studies were included if they recruited adults (≥18 years)
with a body mass index (BMI) of ≥25 kg m−2 (or a BMI of
≥23 kg m−2 in Asian populations). Our focus was on weight
loss interventions for the general population so we
excluded studies in pregnant women, people with eating
disorders and trials of weight loss programmes provided
as a treatment for a particular medical condition. For
example, we would exclude trials where every single par-
ticipant had hypertension and the weight loss programme
was presented as a treatment for hypertension, but include
trials that provided weight loss programmes for almost all
who sought support to lose weight, which were open to
participants with comorbid conditions, including hyperten-
sion and type 2 diabetes.
To be included, interventions had to be structured
weight management programmes, as opposed to non-
specific advice, and had to incorporate diet, physical activ-
ity and a behaviour change strategy. Each component had
to be clearly described (using a pre-defined set of criteria,
see Protocol S1 for detail) and the intervention had to
involve multiple contacts. We included only programmes
where the interventionists were available outside of a trial
context and where the programme was delivered in the
same setting in the trial that would apply in any wider
roll-out. We were interested in behavioural weight mana-
gement programmes specifically, and hence excluded
programmes that involved surgery or medication and
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programmes that aimed to tackle several behavioural issues
such as problem drinking and smoking.
Studies were required to report a measure of weight
change at 12 months or greater from baseline and to
include a control group ranging from no intervention at all
to seeing someone without specific training in delivering a
weight management programme.
Data collection
Titles and abstracts were assessed by a single reviewer with
a sample checked by a second reviewer. Two reviewers
independently conducted data extraction and quality
assessment. Any discrepancies were resolved by discussion,
or where needed, by referral to a third reviewer. As well as
data on participants and outcomes, we extracted descrip-
tive data on the characteristics of the components of the
interventions, the type of person delivering the interven-
tion, the delivery setting and mode, and the behavioural
approaches used, including goals set. Where further detail
was required, we contacted study authors and con-
ducted web searches for treatment protocols and further
publications.
Our primary outcome was difference in mean weight
change between intervention and control at 12 and 24
months. Where outcome data were missing, we contacted
authors for further information. Where available, we also
extracted data on changes in systolic and diastolic blood
pressure, high-density lipoprotein (HDL) and low-density
lipoprotein (LDL) cholesterol, fasting blood glucose,
quality of life, mood, and adverse events. We also extracted
other weight change data as a secondary outcome at 12
months (change in BMI and percentage weight change from
baseline).
Reviewers critically appraised each included study using
criteria developed by the York Centre for Reviews and
Dissemination (11). Risk of bias was assessed on the basis
of generation of the randomization sequence, concealment
of allocation, selective reporting and attrition. Studies were
considered to be at low risk of bias for selective reporting
where all predefined outcomes were reported. In the
absence of formal criteria with which to judge attrition bias
in weight loss studies, we considered studies to be at low
risk of attrition bias if over 50% of participants were
followed up at 12 months and if the percentage followed up
was similar across all arms (<20% difference).
Statistical analysis
To ensure we did not introduce spurious differences in
effectiveness, we presented results using baseline observa-
tion carried forward (BOCF), recalculating where neces-
sary (12). BOCF is an intention-to-treat analysis that
makes the assumption that the weight (or other biomedical
measure) of those who do not attend an assessment is the
same as at baseline. We conducted meta-analyses in
Review Manager 5.2 (The Nordic Cochrane Centre,
Copenhagen, Denmark) to examine the difference in
weight change between intervention groups and control at
12 and 24 months, and to examine changes in biomedical
outcomes at 12 months or longer, where reported (13).
There were insufficient data to meta-analyse adverse
events, quality of life or mood, hence we report these
narratively.
We pooled four subgroups of studies to test an a priori
hypothesis that these groups of programmes would have
different effects: commercial programmes without meal
replacements (all included studies in this category were
group-based, and this subgroup is hence referred to as
‘group-based commercial programmes’ for simplicity);
commercial programmes providing meal replacements;
primary care interventions; and web programmes. We used
a random effects model to account for differences in the
nature of the populations and the interventions being
tested. Pooled results are presented as mean differences in
kilogrammes (kg) with 95% confidence intervals (CI), and
the I2 statistic is used to present statistical heteroge-
neity (14). Where a study contributed more than one inter-
vention arm to a given subgroup, we split the control group
equally to avoid double counting in the pooled result.
Where data allowed, we tested for differences in the
effectiveness of the interventions by subgroups by calculat-
ing the mean difference in weight loss and χ2 test for
differences, using the largest subgroup (group-based com-
mercial programmes) as a reference to improve precision.
Results
The search retrieved 2,210 references in total, 1,966
of which were identified through database searches, 91 of
which were identified from Loveman et al., and 153 of
which were identified from other sources. After screening
titles and abstracts, we excluded 1,894 references that were
not randomized controlled trials of behavioural weight
management programmes, and retrieved full texts for
206 references. Of these, 196 were excluded after full-text
screening, with the most common reason being study
design. Thirty-two references met our criteria for interven-
tion type, participants, outcomes and comparators, but 22
of these were excluded because the interventions were not
delivered in the settings or by the people who might deliver
them in a routine, non-trial context, or because the inter-
vention being tested required substantial infrastructure or
staffing that was not already widely available (Table S2).
The 10 included references represent eight studies, 13 inter-
vention arms and eight control arms in total. A flow chart
detailing the search and screening process can be found in
Fig. S1.
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Characteristics of included studies
The eight included studies represented over 3,700 partici-
pants. The number of participants in each study ranged
from 261 to 1,755, with a mean of 600 participants per
study. Four studies were conducted in the United States,
two were conducted in England, one was conducted in
Switzerland, and one was a multi-centre study conducted in
Australia, Germany and England. The mean age of study
participants ranged from 40 to 52 years, and as is common
in weight loss studies, the majority of participants were
women (ranging from 71% to 100%). The mean BMI
ranged from 31.4 to 39.0 kg m−2. Four of the eight included
studies had an upper limit for baseline BMI: one study of a
commercial programme had a BMI cut-off point of
35 kg m−2 (15); two further studies of commercial pro-
grammes had a cut-off of 40 kg m−2 (16,17); and one study
of a primary care intervention had a cut-off of 50 kg m−2
(18). All studies reported weight change at 12 months from
baseline. Four studies also reported longer follow-ups:
one reported weight change at 18 months and three fol-
lowed up participants at two years. Reporting of secondary
outcomes was sparse, with five of the eight studies report-
ing some biomedical outcomes and fewer than half report-
ing on quality of life, depression or adverse events.
Intervention characteristics are described by a subgroup
below. Further details of the intervention and control arms
for each included study, including diet and physical activity
components, can be found in Tables 1 and 2.
Intervention characteristics
Commercial programmes. Three studies, representing five
intervention arms and 1,605 participants, evaluated
community-based commercial programmes that did not
provide meal replacements. All were group-based. All inter-
ventions were delivered in person, although some provided
additional individual support via phone or Internet. Three
studies provided access to Weight Watchers: two provided
vouchers for weekly sessions for a year or longer (15,16)
and one provided vouchers for 12 weekly sessions (19).
One study also provided vouchers for 12 weekly sessions of
Rosemary Conley or Slimming World (UK-based pro-
grammes) (19). In all programmes, physical activity was
recommended (not supervised), although in one commer-
cial intervention, participants were offered a 45-min dance
class each week (19). Four of the five interventions involved
energy restrictions, and the fifth involved a low-energy
density diet, but did not specify a set energy intake. In two
studies, the control group received multiple contacts from a
generalist with no specific training in weight management
and in one study the control group received one-off advice.
The one study of a commercial intervention providing
meal replacements (Jenny Craig) included 442 participants
in total (17). This study had two intervention arms: one
received in-person counselling and the other received tele-
phone counselling for two years. All counselling were given
weekly and individually. Participants were set a low-fat and
reduced-energy diet including free, pre-packaged meals.
Physical activity was recommended. The control group had
two face-to-face sessions with the research staff, and was
provided with brief written materials.
Primary care-based interventions. Five study arms were
classed as primary care-based interventions, representing
almost 1,000 participants in total. All but one programme
was delivered by staff already based in the practice where
the intervention was delivered (see Tables 1 and 2 for
further detail) (20). An additional study that used trained
lay people was also included as it was judged to require
only minimal additional infrastructure. All interventions
were delivered in person; one in a group setting (21) and
the remainder via one-to-one counselling. There was a wide
range in the frequency and duration of sessions offered,
from 14 weekly sessions to monthly sessions for two years.
Four of the interventions set energy restrictions, and the
fifth restricted fat intake only (21). All programmes recom-
mended physical activity of moderate intensity. Control
groups ranged from multiple sessions with someone
untrained in weight management (two studies), to a single
session (one study) and written advice only (one study).
Web-based programmes. One study of an automated web-
based intervention met our criteria; participants could
submit diet and exercise logs and receive weekly feedback
tailored by a computer algorithm (22). Access was avail-
able for 18 months. The intervention recommended an
increase in moderate and vigorous physical activity. It did
not set an energy prescription, but encouraged reduction in
energy, especially high-energy foods. The study included
over 800 participants. The control group received one
face-to-face counselling session and access to a static,
information-only website (i.e. no interactive components).
Risk of bias
Four of the eight included studies were judged to be at low
risk of bias across all domains (15–18). In two studies (one
primary care, one web-based), the randomization pro-
cedures were not described in enough detail to evaluate risk
of bias (21,22). These two studies were also judged to be at
high risk of attrition bias because of low (22) and differ-
ential (21) rates of follow-up at 12 months. A third study,
which evaluated both commercial and primary care inter-
ventions was also judged to be at high risk of attrition bias
because of differential rates of follow-up (19). Finally, one
study was judged to be at high risk of selection bias as it did
not report all of the outcomes that it had pre-specified (20).
Further details can be found in Table 3.
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Weight change
Commercial programmes
Pooled results from three studies comparing commercial
group-based weight loss programmes (Weight Watchers,
Slimming World and Rosemary Conley) with control
yielded a mean difference of −2.22 kg in favour of the
intervention group, with 95% CI of −2.89 to −1.54 at 12
months (Fig. 1, Hedge’s adjusted g −0.42, 95% CI −0.53 to
−0.30). This represents five intervention arms in total. Sta-
tistical heterogeneity was low (I2 = 20%). In the one study
that reported follow-up at two years, a statistically signifi-
cant difference between intervention and control arms
remained (risk ratio −2.10, 95% CI −3.26 to −0.94, Fig. 2).
The pooled result from two arms testing phone or
in-person delivery of a commercial programme providing
meal replacements (Jenny Craig) showed the programme to
be more effective than minimal intervention at 12 months,
with a mean difference of −6.83 kg (95% CI −8.39 to
−5.26) (Hedge’s adjusted g −0.93, 95% CI −1.21 to −0.65).
At two years, the difference was smaller but still significant
(mean difference −4.97 kg, 95% CI −6.62 to −3.33). At one
and two years, the in-person arm had a slightly greater
mean weight loss than the phone arm, but there was no
statistically significant difference between them at either
follow-up.
Automated Internet intervention
The one study that tested an automated Internet pro-
gramme detected a statistically significant effect of the
intervention at 12 months, but the effect was clinically
small (mean difference −0.70 kg, 95% CI −1.37 to −0.03;
Hedge’s adjusted g −0.13, 95% CI −0.27 to 0.01). At 18
months, there was no difference between intervention and
control arms (mean difference 0.00 kg, 95% CI −0.60 to
0.60).
Interventions delivered by generalists in primary care
Of the five interventions delivered by generalists in primary
care, only one detected a statistically significant effect
(mean difference −3.40, 95% CI −6.16 to −0.64; Hedge’s
adjusted g −0.06, 95% CI −0.19 to 0.07). However, this
was a small study (n = 62) and judged to be at high risk of
bias because of, among other things, significant differences
among groups in terms of baseline variables and attrition
(21). Pooled results from the five primary care interventions
did not detect a statistically significant difference in weight
change between intervention and control groups at 12
months (mean difference −0.45 kg, 95% CI −1.34 to 0.43).
Statistical heterogeneity was moderate (I2 = 35%); a sensi-
tivity analysis removing the one study at high risk of bias
reduced this to 0%. Only one study reported follow-up at
two years; this also did not detect a significant effect (mean
difference −0.90 kg, 95% CI −2.70 to 0.90).
Between-group differences
Subgroups showed varying degrees of weight loss, with
significant between group differences overall (χ2 = 59.3,
P < 0.001, I2 = 94.9%). There were significant differences
between the reference group, group-based commercial pro-
grammes and each of the other types of programmes. The
χ2 difference with commercial programmes providing meal
replacements was χ2 = 28.0, P < 0.001, with automated
Internet programmes χ2 = 9.7, P = 0.002, and with primary
care χ2 = 9.6, P = 0.002.
Changes in other weight outcomes
We also looked at other weight-related outcomes as sec-
ondary outcomes at 12 months. Five out of the eight
included studies reported change in BMI and four out of
the eight reported mean change in percentage of weight at
baseline. In both cases, results mirrored those seen in
weight change, with significant differences observed in
Table 3 Risk of bias judgements for included studies*
Study ID Random
sequence
generation
Allocation
concealment
Attrition Selective
reporting
Notes
Hersey 2012 (22) Unclear Unclear High Low Randomization procedures not described. Follow-up <50% at 12 months
Heshka 2006 (16) Low Low Low Low
Jebb 2011 (15) Low Low Low Low
Jolly 2011 (19) Low Low High Low Between arm differences in rates of follow-up >20%
Munsch 2003 (21) Unclear Unclear High Low Randomization process not described, significant baseline imbalances.
Between arm differences in rates of follow-up >20%
Nanchahal 2011 (20) Low Low Low High Psychological variables measured, but not reported
Rock 2010 (17) Low Low Low Low
Wadden 2011 (18) Low Low Low Low
*Where ‘low’ indicates low risk of bias in that domain, ‘unclear’ indicates insufficient information with which to judge, and ‘high’ indicates high risk of
bias in that domain.
926 Behavioural weight management: meta-analysis J. Hartmann-Boyce et al. obesity reviews
© 2014 The Authors. Obesity Reviews published by John Wiley & Sons Ltd on behalf of World Obesity15, 920–932, November 2014
commercial programmes with and without meal replace-
ments, and no significant effect observed in interventions
delivered in primary care. The study of an automated Inter-
net programme did not report on these outcomes. Results
are tabulated in Table 4, with forest plots in Figs S2 and S3.
Two studies reported percentage of participants who
gained weight between baseline and 12 months: in a group-
based commercial study, 20% of intervention versus 46%
of control participants weighed more at 12 months than
they did at baseline (16), and in a primary care study 30%
intervention versus 41% control weighed more at 12
months than at baseline (18).
Biomedical outcomes
Because of limited data, meta-analyses of biomedical out-
comes involved fewer participants than for weight out-
comes. No significant effects were found, with the
exception of a marginal increase in HDL (mean difference
+0.03 mmol L−1, 95% CI 0.00–0.05, P = 0.02) and
decrease in diastolic blood pressure (mean difference
−0.92 mmHG, 95% CI −1.72 to −0.13) in participants in
group-based commercial programmes. Results are tabu-
lated in Table 5, with forest plots in Figs S4–S8. No signifi-
cant subgroup differences were detected for any biomedical
outcome.
Adverse events
Only one of the eight included studies reported adverse
events (18). This study of a primary care-based intervention
detected no significant between-group differences in serious
adverse events over the two-year trial period (P = 0.56).
One study of a commercial programme with meal replace-
ments administered the Eating Disorder Examination
Questionnaire to participants at baseline and follow-up.
d d
Figure 1 Mean difference in weight change (kg) at 12 months. Note: BWMP, behavioural weight management programme; CI, confidence interval;
GP, general practitioner; RC, Rosemary Conley; SW, Slimming World; SD, standard deviation; WW, Weight Watchers.
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Scores improved over time in all groups, and no significant
between-group differences were detected (17).
Quality of life and depression scales
Five studies measured quality of life at baseline and follow-
up. Of these, two did not report any results and two
studies, one of a commercial group programme and one of
a primary care intervention, did not report numeric results,
but stated that no differences were found between groups
in change in quality of life measures (16,20). The fifth
study, of a commercial weight loss programme providing
meal replacements, also did not detect significant differ-
ences in quality of life between baseline and 12 months in
any groups (17).
Three studies measured depression indices at baseline
and follow-up. One primary care study reported that
depression decreased in the intervention group, but did not
provide numeric figures or report on changes in depression
in the control group (21). In the complete case analysis, the
Figure 2 Mean difference in weight change (kg) at 24 months. Note: BWMP, behavioural weight management programme; CI, confidence interval;
SD, standard deviation.
Table 4 Changes in secondary weight outcomes at 12 months, pooled results using baseline observation carried forward* and random effects
meta-analysis
Outcome Subgroup Number
of studies
Total n Mean difference and 95% CI
Change in BMI Commercial + meal replacements 1 442 −2.5 kg m−2, 95% CI −3.0 to −2.0
Group-based commercial 1 1,020 −1.0 kg m−2, 95% CI −1.5 to −0.5
Primary care 3 712 −0.5 kg m−2, 95% CI −1.0 to +0.1
Change from baseline weight by percentage Commercial + meal replacements 1 442 −7.5%, 95% CI −9.2 to −5.8
Group-based commercial 1 400 −1.5%, 95% CI −2.7 to −0.5
Primary care 3 882 −0.4%, 95% CI −1.2 to +0.5
*Secondary outcomes for Jolly only available in multiple imputation as opposed to baseline observation carried forward form.
BMI, body mass index; CI, confidence interval.
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study of the commercial programme providing meal
replacements detected a significant intervention effect on
the Beck Depression Inventory, with improvements in both
intervention arms at 12 months (17). A further primary
care study found no differences between groups (20).
Discussion
Surprisingly few trials have tested weight loss interventions
delivered in the settings and by the practitioners who would
deliver such interventions in routine practice. Such studies
provide crucial information for informing clinical practice.
The data that were available show evidence that group-
based commercial interventions are effective. Limited evi-
dence suggests that commercial interventions that supply
food are even more effective, although we would temper
drawing conclusions from this as results were from one
study. In addition, the cost of providing meal replacements
is considerably more than purely behavioural support pro-
grammes and less likely to be deployed at scale in routine
practice. There was some evidence, clouded by methodo-
logical concerns, that Internet interventions could be effec-
tive in the short term. The available evidence shows that
interventions delivered by primary care teams are not effec-
tive. Scant evidence on outcomes other than weight change
suggests that these interventions achieve only modest
benefits on blood pressure, lipids, and fasting glucose,
although the power of this review to detect changes was
limited by the fact that few studies reported on these out-
comes. There was insufficient evidence on quality of life but
no evidence this improved or worsened. There was no
evidence that such programmes led to mood problems or
adverse events, but data were limited.
The difference in weight loss between control condition
and commercial weight management support may appear
modest, at 2.2 kg. However, as the control condition lost
over 1 kg in every case, the total weight loss achieved by
people on these programmes is over 3 kg. This is somewhat
equivalent to the increase in mean weight in the United
States over a decade in the latter part of the 20th century
(23), when the prevalence of obesity went from 23% to
31% during one such decade (24). Thus the challenge of
these weight control interventions is to achieve widespread
uptake, which might ‘take a decade off’ the obesity epi-
demic. Doing so could have a modest, but important
impact on population health. For the individuals con-
cerned, a weight reduction of this magnitude, approxi-
mately one BMI unit, would reduce their risk of mortality
by more than 6% (25), decrease the risk of developing
diabetes by over 30% (26), and improve HbA1c and blood
pressure in people already living with type 2 diabetes (27).
There are two major strengths to our review compared
with other reviews in the area. Firstly, we recognize that
delivery of complex behavioural interventions such as
these is a skilled task. Interventions delivered by experts in
ideal contexts may achieve much better results than those
delivered in routine practice. For example, we excluded
outcomes from a study of the Diabetes Prevention
Program because the intervention was delivered by quali-
fied dieticians and people with masters degrees in relevant
areas. In this study, the intervention group lost 6.1 kg
more than the control group at 12 months (28). By con-
trast, a study of an abbreviated version of the same pro-
gramme adapted for use by generalists and included in
our review achieved 0.8 kg greater weight loss than
control (18). By rigorously focusing on the nature of the
Table 5 Changes in biomedical outcomes at 12 months, pooled results using baseline observation carried forward and random effects meta-analysis
Outcome Subgroup Number
of studies
Total n Mean difference and 95% CI
Blood pressure (systolic) Group-based commercial 2 1,195 −0.8 mmHg, 95% CI −2.0 to 0.4
Primary care 2 642 −0.2 mmHg, 95% CI −2.3 to 1.8
Blood pressure (diastolic) Group-based commercial 2 1,195 −0.9 mmHg, 95% CI −1.7 to −0.1
Primary care 2* 642 −0.6 mmHg, 95% CI −1.9 to 0.8
Lipids (LDL) Commercial with meal replacements 1 442 0.15 mmol L−1, 95% CI −0.10 to 0.40
Group-based commercial 1 772 −0.07 mmol L−1, 95% CI −0.14 to 0.00
Primary care 1 261 0.07 mmol L−1, 95% CI −0.10 to 0.24
Lipids (HDL) Commercial with meal replacements 1 442 0.02 mmol L−1, 95% CI −0.01 to 0.05
Group-based commercial 3 1,195 0.03 mmol L−1, 95% CI 0.00–0.05, P = 0.02
Primary care 1 261 −0.02 mmol L−1, 95% CI −0.07 to 0.03
Fasting glucose Group-based commercial 2 1,195 −0.03 mmol L−1, 95% CI −0.08 to 0.02
Primary care 1 261 −0.25 mmol L−1, 95% CI −0.56 to 0.06
*One additional study based in primary care did not present results by study arm and hence was not included in the comparison. A significant
reduction in blood pressure was reported across all participants who had hypertension at baseline.
CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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implementation, we have shown what is currently known
about what can and cannot be achieved in weight man-
agement in the ‘real world’.
Secondly, weight loss studies vary greatly in how they
present weight loss data, and previous reviews have taken
weight loss as reported and summarized this. As attrition is
often substantial in these trials, combining data presented in
different ways can lead to spurious differences between
studies. To ensure a consistent approach to weight change
outcomes from all included studies, there are only two
methods open to the reviewer: complete case analysis and
imputation via BOCF. We used previously published
methods to calculate BOCF and used these data as our
primary outcome. BOCF is an appropriate means of impu-
tation as it provides a conservative estimate suitable for
assessing population benefit. Although complete case data
were available formost included studies, we favoured BOCF
as amore conservative approach. A sensitivity analysis using
complete case data produced similar results (Fig. S9).
Reporting BOCF as an outcome in future trials, whether as
a sensitivity analysis or as an aid to future evidence synthesis,
will enable these meta-analyses to be readily updated.
Our scope and approach to data synthesis differ from
other reviews in this area, and thus offer a different
perspective designed to be more suitable for informing
current clinical practice. In terms of scope, our review is
most similar to a 2011 review of primary care-relevant
treatments, conducted on behalf of the U.S. Preventive
Services Task Force, which included studies conducted in
primary care and studies that tested programmes that
could, in theory, operate in or be referred to from primary
care (29). The authors’ approach differed from ours in
several key respects: they do not exclude efficacy trials;
they do not consider primary care-delivered interventions
separately from those that could be referred to from
primary care; they use weight change data as reported;
and their inclusion criteria allow for non-randomized con-
trolled trials and single component interventions. Their
overall pooled effect is consistent with our results from
commercial weight management programmes only; by
separately evaluating those interventions delivered in
primary care by generalists, our results present a more
nuanced picture. Other reviews have chosen to focus
either on commercial programmes or those delivered in
primary care. Incorporating three recent trials, our
meta-analysis produces more convincing findings that
commercial weight management programmes can induce
significant weight loss at one year and longer than a 2005
review by Tsai and colleagues (9), which concluded that,
with the exception of one trial of Weight Watchers (16),
evidence was suboptimal. Our results are consistent with
those of a 2013 narrative review of obesity management
in primary care, which found that current evidence does
not support the use of low- to moderate-intensity primary
care counselling for obesity and sounded a note of caution
as to the transferability of the more intensive interventions
that had been tested (10). By conducting a meta-analysis,
we are able to support this conclusion with numeric esti-
mates of the effects of such programmes.
There are several limitations of our review. Firstly, BOCF,
aswith all imputationmethods, has limitations, although, as
discussed earlier, use of BOCF removed a possible reason for
spurious differences among studies, and our findings were
not sensitive to the use of BOCF as opposed to complete case
data (30). Secondly, our inclusion criteria were deliberately
strict. There is evidence that diet and exercise lead to greater
weight loss than either alone (31–33), and hence we focused
on multicomponent interventions containing diet, exercise
and behaviour. We also included only those interventions
judged to be readily transferable into routine practice. This
meant that we excluded studies delivered by specialists in
primary care settings, as it was not clear from trial reports if
staff were already employed by the practices or were hired in
to deliver the intervention. However, a sensitivity analysis
including these studies did not affect the overall results.
Furthermore, despite attempts to contact authors, several
studies with insufficient or inappropriate data had to be
excluded. Finally, given the small number of studies, we
were unable to formally test for publication bias, and given
the lack of reporting of secondary outcomes, wewere unable
to draw conclusions as to the impact of such programmes on
biomedical results. In addition, because of limited reporting
of intervention characteristics, we aremissing some detail on
programme content thatmay have added further context, an
issue that we have also noted in efficacy trials (34). Our
results were further limited by the quality of included
studies, with only half rated at low risk of bias.
Although we did not evaluate cost-effectiveness, cost-
effectiveness analyses are available for two of our included
studies (one commercial, one Internet). Both found the
intervention to be cost-effective (22,35). Many primary
care practices in the United Kingdom and the United States
are currently referring patients to commercial weight loss
services, and findings from our review support this course
of action (10,36). This analysis is unable to establish why
programmes delivered by primary care staff appear less
likely to induce significant weight loss than commercial
programmes. As with the commercial programmes, to be
included, primary care programmes were required to be
complex interventions with multiple contacts, and unpub-
lished data suggest that there were few differences in the
delivery, training and behavioural change techniques used
by commercial and primary care programmes. Our findings
are also consistent with evidence from direct comparisons
(19). It would be helpful to understand the reasons for the
lack of efficacy of primary care programmes and to rectify
this, especially given that commercial programmes may not
be available or suited to everyone, and in light of evidence
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that some people would prefer a primary care-delivered
programme over a commercial one (19,37).
Our analyses add to the body of evidence by demonstrat-
ing that some behavioural weight management pro-
grammes can lead to significant weight loss at one year and
sometimes longer without requiring major changes to
current staffing or infrastructure. However, our results
suggest only a limited range of current options with regard
to such programmes, with promising evidence, albeit
limited by a small number of studies, of the effectiveness of
commercial programmes and disappointing results from
programmes delivered by generalists within primary care
settings. This review highlights the need for further
research into the reasons for the lack of efficacy of primary
care programmes being tested and for further studies of
web-based interventions. Future studies of weight loss
interventions should carefully consider their subsequent
applicability (e.g. staffing, location and other resources) to
routine practice.
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